A reappraisal of isoproterenol in goal-directed therapy of septic shock

Shock

Volumn 26, Issue 4, 2006, Pages 353-357

  Leone, Marc ^a   Boyadjiev, Ioanna ^a   Boulos, Emile ^a   Antonini, François ^a   Visintini, Pierre ^a   Albanèse, Jacques ^a   Martin, Claude ^a  

^a HÔPITAL NORD   (France)

Author keywords

Beta receptor; Cardiac depression; Cardiac index; Catecholamine; Hemodynamics; Oxygen

Indexed keywords

ISOPRENALINE; LACTIC ACID;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANEMIA; ARTERIAL OXYGEN SATURATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAPHY; EVALUATION; FEMALE; HEART DISEASE; HEMODYNAMICS; HUMAN; HYPOXEMIA; MALE; MEAN ARTERIAL PRESSURE; OXYGEN SATURATION; SEPTIC SHOCK;

ADRENERGIC BETA-AGONISTS; ADULT; AGED; FEMALE; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; SHOCK, SEPTIC;

EID: 33748741725     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000226345.55657.66     Document Type: Article

References (32)

1. Puri PS: Modification of experimental myocardial infarct size by cardiac drugs. Am J Cardiol 33:521-528, 1974.
2. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377, 2001.
3. Levy RJ, Deutschman CS: Evaluating myocardial depression in sepsis. Shock 22:1-10, 2004.
4. Ammann P, Pfisterer M, Fehr T, Rickli H: Raised cardiac troponins. BMJ 328:1028-1029, 2004.
5. Rackow E, Weil M: Systemic response to sepsis. Crit Care Med 17:483, 1989.
6. Leone M, Vallet B, Teboul J, Mateo J, Bastien O, Martin C: Survey of the use of catecholamines by French physicians. Intensive Care Med 30:984-988, 2004.
7. Martin RS, Kincaid EH, Russell HM, Meredith JW, Chang MC: Selective management of cardiovascular dysfunction in posttraumatic SIRS and sepsis. Shock 23:202-208, 2005.
8. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: International Sepsis Definitions Conference: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29:530-538, 2003.
9. Bourgoin A, Leone M, Delmas A, Garnier F, Albanese J, Martin C: Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 33:780-786, 2005.
10. Leone M, Boutiere-Albanese B, Valette S, Camoin-Jau L, Barrau K, Albanese J, Martin C, Dignat-George F: Cell adhesion molecules as a marker reflecting the reduction of endothelial activation induced by glucocorticoids. Shock 21:311-314, 2004.
11. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, et al.: Surviving Sepsis Campaign Management Guidelines Committee: surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858-873, 2004.
12. Pinsky MR, Teboul JL: Assessment of indices of preload and volume responsiveness. Curr Opin Crit Care 11235-11239, 2005.
13. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, et al.: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32:1928-1948, 2004.
14. Starzecki B, Spink W: Hemodynamic effects of isoproterenol in canine endotoxin shock. J Clin Invest 47:2193-2205, 1968.
15. Brown R, Carey J, Mohr P, Monson DO, Shoemaker WC: Comparative evaluation of sympathomimetic amines in clinical shock. Circulation 34:260-271, 1966.
16. Munt B, Jue J, Gin K, Fenwick J, Tweeddale M: Diastolic filling in human severe sepsis: an echocardiographic study. Crit Care Med 26:1829-1833, 1998.
17. Martin C, Viviand X, Arnaud S, Vialet R, Rougnon T: Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients. Crit Care Med 27:1708-1713, 1999.
18. Martin C, Viviand X, Leone M, Thirion X: Effect of norepinephrine on the outcome of septic shock. Crit Care Med 28:2758-2765, 2000.
19. Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri VM, De Backer D, Payen D: Does dopamine administration in shock influence outcome? Results of the sepsis occurrence in acutely ill patients (SOAP) study. Crit Care Med 34:589-597, 2006.
20. Nikolaidis L, Hentosz T, Doverspike A, Huerbin R, Stolarski C, Shen YT, Shannon RP: Catecholamine stimulation is associated with impaired myocardial O(2) utilization in heart failure. Cardiovasc Res 53:392-404, 2002.
21. MacLean L, Mulligan W, McLean A, Duff JH: Patterns of septic shock in man - a detailed study of 56 patients. Ann Surg 166:543-562, 1967.
22. Worthley LI, Tyler P, Moran JL: A comparison of dopamine, dobutamine and isoproterenol in the treatment of shock. Intensive Care Med 11:13-19, 1985.
23. Kersting F, Follath F, Moulds R, Mucklow J, McCloy R, Sheares J, Dollery C: A comparison of cardiovascular effects of dobutamine and isoprenaline after open heart surgery. Br Heart J 38:622-626, 1976.
24. Takashima S, Schlidt S, Koukoulis G, Sevala M, Egan TM: Isoproterenol reduces ischemia-reperfusion lung injury despite beta-blockade. J Surg Res 126:114-120, 2005.
25. Leone M., Albanese J, Delmas A, Chaabane W, Garnier F, Martin C: Terlipressin in catecholamine-resistant septic shock patients. Shock 22:314-319, 2004.
26. Levy B, Dusang B, Annane D, Gibot S, Bollaert PE: College Interregional des Reanimateurs du Nord-Est: cardiovascular response to dopamine and early prediction of outcome in septic shock: a prospective multiple-center study. Crit Care Med 33:2172-2177, 2005.
27. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B: CUB-Rea Network: current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 168:165-172, 2003.
28. Leone M, Albanese J, Martin C: Positive inotropic stimulation. Curr Opin Crit Care 8:395-403, 2002.
29. Morelli A, De Castro S, Teboul J, Singer M, Rocco M, Conti G, De Luca L, Di Angelantonio E, Orecchioni A, Pandian NG, et al.: Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31:638-644, 2005.
30. Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, Tomlanovich MC: Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 32:1637-1642, 2004.
31. Levy B, Sadoune LO, Gelot AM, Bollaert PE, Nabet P, Larcan A: Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med 28:114-119, 2000.
32. Young JB: New therapeutic choices in the management of acute congestive heart failure. Rev Cardiovasc Med 2(Suppl 2):S19-S24, 2001.